Hostname: page-component-8448b6f56d-qsmjn Total loading time: 0 Render date: 2024-04-23T13:36:30.231Z Has data issue: false hasContentIssue false

Deanol in Depression

A Controlled Trial

Published online by Cambridge University Press:  08 February 2018

J. Dominian*
Affiliation:
The Bethlem Royal Hospital and The Maudsley Hospital

Extract

The management of mild depression and its concomitant associated symptoms of general debility presents a constant and widespread challenge to psychiatry both in hospital and in general practice. It is inevitable that at some stage resort will be made to drugs. This is a tempting pharmacological field and the level of interest is indicated by the available plethora of alternatives. A recently introduced drug in current use and purported to be of use specifically in this field is Deanol (Deaner) which is the p-acetamidobenzoic acid salt of 2-dimethyl-aminoethanol or Atrol which is the bitartrate of the same base.

Type
Original Articles
Copyright
Copyright © Royal College of Psychiatrists, 1960 

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

Lemere, F., and Lasater, H. H., Amer. J. Psychiat., 1958, 114, 655.Google Scholar
Moriarty, J. D., and Mebane, J. C., ibid., 1959, 115, 941.Google Scholar
Pfeiffer, C. C., et al., Science, 1957, 126, 610.Google Scholar
Submit a response

eLetters

No eLetters have been published for this article.